Merck Tbk. vs Ristia Bintang Mahkotasejati Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Ristia Bintang Mahkotasejati Tbk. trades at Rp69 (market cap 154.06B, 373.84M 24h volume). The key difference: Merck Tbk. is far larger — about 11× Ristia Bintang Mahkotasejati Tbk.'s market cap, and Ristia Bintang Mahkotasejati Tbk. is more actively traded (373.84M versus 37.6K). Which is the better fit depends on your goals.
| MERK | RBMS | |
|---|---|---|
Market Cap | 1.7T | 154.06B |
Volume | 37.6K | 373.84M |
Lot | 376 | 3.74M |
Turnover | 144.47M | 24.62B |
Average Price | 3,842.23 | 65.86 |
Value | 144.47M | 24.62B |
Indicative Equilibrium Price | 3,840 | 69 |
Indicative Equilibrium Volume | 7 | 173.84K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.
Read more on RBMS →